US Patent Issued to Slingshot Biosciences on Aug. 5 for "Engineered particles as red blood cell mimics and compositions containing same for hematology" (California Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,379,387, issued on Aug. 5, was assigned to Slingshot Biosciences Inc. (Emeryville, Calif.).

"Engineered particles as red blood cell mimics and compositions containing same for hematology" was invented by Daixuan Zhang (Fremont, Calif.), Jeffrey Kim (Berkeley, Calif.) and Keunho Ahn (Pleasanton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are red blood cell control compositions containing one or more populations of lysable hydrogel particles having an impedance that is substantially similar to the impedance of a human red blood cell of average diameter; and a population of hemoglobin molecules or a population of dye molecules tha...